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Abstract
Background: Cellular senescence is a permanent growth arrest that occurs in response to cellular stressors, such as 
telomere shortening or activation of oncogenes. Although the process of senescence growth arrest is somewhat 
conserved between mouse and human cells, there are some critical differences in the molecular pathways of 
senescence between these two species. Recent studies in human fibroblasts have defined a cell signaling pathway that 
is initiated by repression of a specific Wnt ligand, Wnt2. This, in turn, activates a histone chaperone HIRA, and 
culminates in formation of specialized punctate domains of facultative heterochromatin, called Senescence-
Associated Heterochromatin Foci (SAHF), that are enriched in the histone variant, macroH2A. SAHF are thought to 
repress expression of proliferation-promoting genes, thereby contributing to senescence-associated proliferation 
arrest. We asked whether this Wnt2-HIRA-SAHF pathway is conserved in mouse fibroblasts.
Results: We show that mouse embryo fibroblasts (MEFs) and mouse skin fibroblasts, do not form robust punctate 
SAHF in response to an activated Ras oncogene or shortened telomeres. However, senescent MEFs do exhibit elevated 
levels of macroH2A staining throughout the nucleus as a whole. Consistent with their failure to fully activate the SAHF 
assembly pathway, the Wnt2-HIRA signaling axis is not overtly regulated between proliferating and senescent mouse 
cells.
Conclusions: In addition to the previously defined differences between mouse and human cells in the mechanisms 
and phenotypes associated with senescence, we conclude that senescent mouse and human fibroblasts also differ at 
the level of chromatin and the signaling pathways used to regulate chromatin. These differences between human and 
mouse senescence may contribute to the increased propensity of mouse fibroblasts (and perhaps other mouse cell 
types) to become immortalized and transformed, compared to human cells.
Background
Cellular senescence is an irreversible proliferation arrest
that is an important tumor suppression mechanism and
i s  a l s o  t h o u g h t  t o  c o n t r i b u t e  t o  o r g a n i s m a l  a g i n g  [ 1 ] .
Senescence occurs in response to various cell stresses,
including activated oncogenes, critically short telomeres
or DNA damage. Senescence as a response to shortened
telomeres is termed replicative senescence, and as a
response to oncogene activation is termed oncogene-
induced senescence. By permanently exiting the cell cycle
in the presence of an activated oncogene or exposed
telomere ends, the cell is thought to prevent acquisition
of additional genetic alterations and possible transforma-
tion. In this way, senescence is thought to contribute to
tumor suppression. However, senescence may come at a
cost to the organism, as this process is also thought to
lead to exhaustion of stem cell populations and subse-
quent tissue and organismal aging.
Comparison of senescence signaling pathways in
mouse and human cells has revealed some similarities,
but also many differences, between the senescence pro-
grams of these two most-studied species [2]. These differ-
ences might bear on the different longevity and tumor
suppression capacity of these species. Cellular senescence
is induced by concerted activity of the p53 and pRB
tumor suppressor pathways in most primary human cells,
including fibroblasts [3,4]. The pRB protein contributes
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to cell cycle arrest via its inhibitory effects on E2F family
members, transcriptional activators of S-phase genes [5].
The p53 protein also drives many aspects of the senes-
cence program, including cell cycle arrest via transcrip-
tional activation of its downstream effector p21, a cyclin
dependent kinase inhibitor [6]. In mouse fibroblasts,
inactivation of either the p53 pathway or pRB (together
with related proteins, p107 and p130) is generally suffi-
cient to abrogate senescence [7-9]. In contrast, in human
fibroblasts, inactivation of both pathways is required to
inactivate senescence [3,4,10]. Another important differ-
ence between mouse and human cells with respect to
senescence induction is expression of telomerase.
Because of the 'end-replication problem' and lack of a
robust telomere maintenance mechanism, in most prolif-
erating human cells telomeres have potential to become
critically short, and thus be sensed as DNA damage and
so induce senescence [1]. Mouse somatic cells, however,
express telomerase and contain markedly longer telom-
eres, and thus telomere shortening does not appear to
contribute to mouse cell senescence [11-14].
A hallmark of many cultured human cells that have
undergone senescence is the formation of regions of
characteristically punctate heterochromatin, termed
Senescence Associated Heterochromatin Foci (SAHF)
[15,16]. The formation of heterochromatin in senescent
cells is thought to contribute to permanent growth arrest
by silencing proliferating promoting genes, such as cyclin
A2, within dense regions of transcriptionally inactive het-
erochromatin. In human cells, SAHF can be visualized by
conventional epifluorescence microscopy as punctate
domains of DAPI-stained chromatin. These areas of het-
erochromatin also have been shown to harbor various
well-characterized heterochromatin proteins, such as
Heterochromatin Protein 1 (HP1) and histone variant
macroH2A.
We have shown previously that in human cells canoni-
cal Wnt signaling is an important regulator of SAHF for-
mation [17]. Wnt ligands are extracellular signaling
molecules that are important regulators of development,
body axis formation and stem cell renewal [18]. Canoni-
cal Wnts ligands, when they bind to their cognate trans-
membrane frizzled receptors, cause disruption of a
complex of proteins, including Axin, APC and Glycogen
Synthase Kinase 3 (GSK3 (α and β isoforms). In turn, this
results in a block to phosphorylation and degradation of a
GSK3 substrate, β-catenin, a key transcription effector of
canonical Wnt ligands. In pre-senescent primary human
fibroblasts, expression of the canonical Wnt ligand,
Wnt2, is down-regulated, leading to activation of GSK3β
which phosphorylates another of its substrates, the his-
tone chaperone protein, HIRA. As a histone chaperone,
HIRA is able to assemble DNA and histones into
nucleosomes [19]. When phosphorylated by GSK3β on
serine 697, HIRA translocates to specific subnuclear
organelles, termed nuclear PML bodies [17]. This translo-
cation of HIRA to PML bodies is a pre-requisite for HIRA
to promote formation of punctate SAHF in human cells
[20], presumably dependent on its histone chaperone
activity. In human cells, formation of SAHF also depends
on a functional pRB pathway [15,21]. Hence, in human
fibroblasts, the Wnt2-HIRA-SAHF signaling axis and the
pRB tumor suppressor pathway coordinately regulate for-
mation of SAHF.
In light of differences between mouse and human fibro-
blasts in their utilization of the p53 and pRB pathways,
and the impact of telomeres on senescence, we hypothe-
sized that there might be differences in the Wnt2-HIRA-
SAHF signaling pathway between senescence in mouse
and human fibroblasts. Therefore, we sought to deter-
m ine  w het he r  t his  pa t h wa y  is  also r egula t ed as  m ouse
fibroblasts enter senescence.
Results
Senescent mouse fibroblasts do not form robust SAHF
Most cultured primary human fibroblasts, including
IMR90, WI38 and BJ strains, exhibit formation of SAHF
in response to an activated H-Ras oncogene, typically
delivered via a retrovirus ([15] and data not shown). In
order to address whether primary mouse fibroblasts simi-
larly form SAHF when senescent, we transduced primary
Mouse Embryonic Fibroblasts (MEFs) with a constitu-
tively active form of H-Ras (H-RasG12V) and assessed
changes in chromatin by DAPI staining. As shown previ-
ously, in the presence of an activated Ras oncogene, both
human fibroblasts (IMR90) and MEFs ceased proliferat-
ing, whereas controls transduced with vector alone con-
tinued to proliferate (data not shown). The Ras-infected
MEFs also acquired a characteristic senescent morphol-
ogy, typically large, flat, vacuolated and often multi-
nucleate, and expressed Senescence-Associated β-galac-
tosidase (SA β-gal) activity (Figure 1a). As expected, Ras-
expressing human fibroblasts formed marked SAHF
revealed by punctate DAPI-stained domains, which were
a b s e n t  f r o m  c o n t r o l - i n f e c t e d  c e l l s .  H o w e v e r ,  t h e  v a s t
majority of MEFs exhibited no discernible change in their
chromatin in this assay (Figure 1b). Of note, even prolif-
erating MEFs harbor clearly visible domains of bright
DAPI-stained constitutive pericentromeric heterochro-
matin [22,23], and this remained visible in senescent
MEFs. Only a small minority of Ras-expressing MEFs
appeared to show a marked change in chromatin confor-
mation in this assay, reflected in formation of apparently
larger domains of bright DAPI-stained chromatin (Figure
1c-d). Characteristically, these domains of heterochroma-
tin were not only larger than the domains of pericentro-
meric heterochromatin in proliferating MEFs, but were
also fewer in number. Although these cells were apparentKennedy et al. Cell Division 2010, 5:16
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Figure 1 Lack of marked chromatin changes in senescent mouse fibroblasts. (a) SA β-gal staining in MEFs transduced with either control or H-
RasG12V, drug selected and stained 7 days after drug selection. (b) DAPI staining of nuclei of cells shown in (a) and human IMR90. (c) MEF nucleus 
with exceptionally condensed heterochromatin. (d) Percent cells with condensed chromatin in senescent MEFs or IMR90 cells. In IMR90, cells with 
characteristic SAHF as in (b) were scored as positive. In MEFs, only cells with exceptional compaction as in (c) were scored as positive. Pericentromeric 
heterochromatin of normal MEFs as in (b) was not scored as positive. (e) DAPI staining of wild type mouse skin fibroblasts and generation 5 TERC-/-, 
WRN-/- skin fibroblasts.Kennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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by microscopy, the extent of their increase in senescence
did not reach significance (Figure 1d). In sum, this result
shows that onset of oncogene-induced senescence in
most MEFs is not associated with marked changes in
chromatin structure, as measured by DAPI staining.
Another trigger of senescence and SAHF formation in
human cells is shortened telomeres, associated with repli-
cative senescence [21]. To ask whether shortened telom-
eres can trigger SAHF formation in mouse cells, we
compared wild type mouse skin fibroblasts and skin
fibroblasts from generation seven mice lacking both the
telomerase catalytic subunit and the Werner's helicase
(TERC-/-, WRN-/-). The telomeres of these cells are
functionally compromised, leading to marked impair-
ment of cell proliferation and indicators of senescence
[24]. However, even when these cells arrested prolifera-
tion, we did not observe marked changes in chromatin
structure by this assay (Figure 1e). These results indicate
that neither activated oncogenes nor shortened telomeres
induce changes in chromatin structure in mouse cells that
are as marked as those observed in human cells.
In order to investigate further the status of chromatin
in senescent MEFs, we examined the incorporation of
one component of SAHF, the histone variant macroH2A,
by immunofluorescence. MacroH2A is important in het-
erochromatin mediated silencing of the female X chro-
mosome and as such, in control female-derived human
fibroblast IMR90 cells, the barr body stains positively for
this protein (Figure 2a) [25]. In addition, as shown previ-
ously, macroH2A is incorporated into SAHF in these cells
[26]. When we examined MEFs made senescent by trans-
duction of activated Ras (Figure 2b-c), we found that
there was an increase in macroH2A staining in many
senescent cells, compared to proliferating cells (p < 1 ×
10-11). Interestingly, this increase in macroH2A staining
was most apparent in the small proportion of cells that
did show some chromatin compaction in senescent cells
(Figure 1c and 2c).
Together, these microscopy-based assays reveal both
differences and similarities in chromatin regulation
between senescent human fibroblasts and MEFs. A size-
able proportion of the population does show an increase
in macroH2A staining throughout the cell nucleus. How-
ever, unlike human fibroblasts, the majority of MEFs do
not exhibit pronounced changes in chromatin as they
become senescent, as judged by formation of DAPI- or
macroH2A-stained puncta.
Senescent mouse fibroblasts do not recruit HIRA to PML 
bodies
Given the established link between HIRA's localization to
PML bodies and formation of SAHF in senescent human
fibroblasts [26], we questioned whether the failure of
senescent mouse cells to form robust punctate SAHF is
linked to different regulation of HIRA in these cells. As
before, MEFs were made senescent by transduction with
an activated Ras oncogene, and senescence confirmed by
decreased incoporation of BrdU and positive staining for
SA β-gal (data not shown). However, when we compared
the subcellular localization of HIRA in proliferating and
senescent MEFs and human fibroblasts, we found that
HIRA was recruited to PML bodies in senescent human
fibroblasts, but not senescent MEFs (Figure 3a and Addi-
tional file 1: Figure S1). Of particular significance, HIRA
did not localize to PML bodies even in the small propor-
tion of senescent MEFs that did contain compacted het-
erochromatin, as revealed by DAPI staining (Figure 1c
and data not shown). We confirmed that the HIRA pro-
tein was expressed in MEFs, and reactive with the same
mouse monoclonal antibody used for immunofluores-
cence (Figure 3b). We also verified that in MEFs, HIRA
binds to its partner ASF1a, an interaction shown to be
critical for formation of SAHF (Figure 3c) [26]. Similar
confirmatory results were also obtained with two rabbit
polyclonal antibodies to HIRA (data not shown). We also
failed to observe HIRA localized to PML bodies in TERC-
/-, WRN-/- skin fibroblasts (Figure 3d). These results
indicate that the HIRA chaperone is regulated differently
during senescence of mouse and human fibroblasts. Spe-
cifically, HIRA is not recruited to PML bodies as MEFs
become senescent.
Senescent MEFs do not downregulate expression of Wnt2
In human cells, an early trigger of senescence and recruit-
ment of HIRA to PML bodies is repression of a specific
Wnt ligand, Wnt2 [17]. Therefore, we next examined
whether MEFs downregulate expression of this specific
Wnt ligand. We performed RT-PCR analysis in proliferat-
ing and senescent MEFs to determine whether the
expression of Wnt2 changed as the cells senesced. Senes-
cence of MEFs was confirmed by appropriate morpholog-
ical changes and expression of SA β-gal (data not shown).
Unlike senescent IMR90 cells, which were compared in
parallel as a control, we found that MEFs do not down-
regulate expression of Wnt2 as they undergo oncogene-
induced senescence (Figure 4a-b). This observation
extends the differences in regulation of the Wnt2-HIRA-
SAHF pathway in MEFs and human fibroblasts.
Forced activation of GSK3 does not regulate HIRA and SAHF 
in MEFs
In human fibroblasts, recruitment of HIRA to PML bod-
ies depends on repression of expression of Wnt2 and con-
sequent activation of GSK3 [17]. Forced activation of
GSK3, specifically the GSK3β isoform, has been shown to
trigger HIRA's recruitment to PML bodies and formation
of SAHF. To test whether GSK3β can similarly induce
HIRA relocalization and formation of SAHF in MEFs, weKennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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Figure 2 Senescent MEFs stain more intensely with histone variant macroH2A. (a) Human IMR90 fibroblasts transduced with either control or 
H-RasG12V were stained for histone variant macroH2A and DNA (DAPI). Inactive X chromosome is enriched in macroH2A in female cells (arrow). (b) 
Control or H-RasG12V-transduced senescent MEFs were stained for histone variant macroH2A. Results were quantitated using metamorph and ex-
pressed as histograms and box plots: The red line is the median (50th percentile); the box itself encompasses the 25th and 75th percentiles (Inter 
Quartile Range (IQR)); the whiskers are the most extreme data points within 1.5 × IQR; crosses outside the whiskers are outliers. (c) Images of cells 
stained as in (b). White arrows indicate a cell with increased macroH2A stain.Kennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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utilized a mutant, GSK3βS9A. In this mutant, the change
from serine to alanine at amino acid nine prevents inhibi-
tory phosphorylation of GSK3β [27]. We transduced both
human and mouse cells with GSK3βS9A or control vec-
tor, and compared HIRA foci and SAHF formation
between species. As expected, GSK3βS9A induced HIRA
foci and SAHF formation in senescent human cells (Fig-
ure 5a). However, this mutant lacked comparable activity
Figure 3 HIRA is not recruited to PML bodies in senescent MEFs. (a) Localization of HIRA in control and H-RasG12V transduced IMR90 cells or MEFs 
was analyzed by immunofluorescence. (b) Expression of HIRA in IMR90 cells and MEFs was verified by western blotting. Actin serves as loading control. 
(c) Immunoprecipitation-western analysis showing the interaction between HIRA and ASF1a in MEFs. (d) Localization of HIRA and PML in wild type 
and generation 5 TERC-/-, WRN-/- skin fibroblasts was analyzed by immunofluorescenceKennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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in MEFs (Figure 5a-b). We verified that the V5-tagged-
GSK3βS9A was expressed in both MEFs and human
fibroblasts by western blotting (Figure 5c). These experi-
ments reveal another difference between human fibro-
blasts and MEFs. Specifically, that forced activation of
GSK3β is able to activate the Wnt2-HIRA-SAHF pathway
in human fibroblasts, but not MEFs.
Discussion
In both mice and humans, cellular senescence is thought
to contribute to tumor suppression and tissue aging [1].
However, humans and mice show very different lifespans
and tumor suppression capabilities. Specifically, humans
can live 80 years or more and often suppress the onset of
cancer for that long, whereas mice live 2-3 years and can
often be afflicted by cancer in that time. That the basis for
these profoundly important differences can be at least
partly explained at a cellular level, rather than a systemic
one, is underscored by the finding that mouse cells are
much easier to transform in vitro than are human cells
[28,29]. Of note, these seminal studies were performed in
fibroblasts. In light of this, it is important to describe and
understand the differences between the cellular senes-
cence programs of mouse and human fibroblasts. To that
end, several differences have already been identified,
notably in the relative roles of the pRB pathway and in
shortened telomeres.
In this study, we have compared the regulation of the
Wnt2-HIRA-SAHF pathway in senescent mouse and
human fibroblasts. In doing so, we have uncovered addi-
tional differences between these two model systems of
senescence. First, mouse fibroblasts differ from human
fibroblasts in their ability to form robust punctate SAHF.
Specifically, unlike human fibroblasts, the majority of
mouse fibroblasts do not exhibit pronounced changes in
chromatin as they become senescent, as judged by forma-
tion of DAPI- and macroH2A-stained foci. Interestingly,
however, a considerable proportion of the population
does show increased macroH2A staining, without
marked change in organization revealed by DAPI-stain-
ing. A small population, which did not reach statistical
significance in these studies, did appear to exhibit nuclear
reorganization and chromatin compaction, based on
DAPI and macroH2A staining. Second, senescent mouse
fibroblasts do not recruit the histone chaperone HIRA to
PML bodies. Third, MEFs that have been induced to
senesce in response to activated Ras do not downregulate
expression of Wnt2. Fourth, while ectopic expression of
uninhibitable GSK3β in human fibroblasts is sufficient to
trigger recruitment of HIRA to PML bodies and forma-
tion of SAHF in human cells, it fails to do so when ectop-
ically expressed in MEFs. Together, these results indicate
that, compared to human fibroblasts, mouse fibroblasts
are markedly impaired in their ability to activate and sig-
nal through the Wnt2-HIRA-SAHF pathway.
More specifically, these results point to at least two dif-
ferences between human fibroblasts and mouse fibro-
blasts in this Wnt2-HIRA-SAHF pathway. First,
senescence of mouse fibroblasts is not associated with the
trigger that is responsible for activation of this pathway in
human cells, namely repression of Wnt2. Second, mouse
fibroblasts and human fibroblasts also differ downstream
of Wnt2, as indicated by the ability of GSK3βS9A to
induce SAHF in human, but not mouse, fibroblasts. Why
senescent mouse fibroblasts fail to repress expression of
Wnt2, and the difference between mouse and human
fibroblasts downstream of Wnt2, are issues that remain to
be resolved. Regardless of the basis for these differences,
it will ultimately be important to determine whether the
relative ease of transformation of mouse cells, compared
to human cells [28,29], stems, at least in part, from their
Figure 4 Senescent MEFs do not downregulate expression of 
Wnt2. (a) Semiquantitative RT-PCR analysis of expression of Wnt2 and 
GAPDH in MEFs and IMR90 cells. (b) Quantitative RT-PCR analysis of ex-
pression of Wnt2 and GAPDH in MEFs and IMR90 cells.Kennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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failure to regulate this Wnt2-HIRA-SAHF axis, a candi-
date tumor suppressor pathway.
The mechanism by which HIRA's recruitment to PML
bodies contributes to formation of SAHF is not well
understood. Previous studies have indicated that HIRA's
relocation to this subnuclear organelle is required for for-
mation of SAHF, because blocking its relocalization,
either with a dominant negative HIRA mutant or with the
Figure 5 The HIRA-SAHF pathway is not induced by activated GSK3βS9A in MEFs. (a) Localization of HIRA and PML in control virus and H-
RasG12V-transduced senescent IMR90 cells was examined by immunofluorescence. (b) MEFs examined as in (a). (c) DAPI-staining of representative 
cells from (a) and (b). (d) Expression of transduced constructs was verified by western blotting V5-tagged GSK3βS9A or Ras.Kennedy et al. Cell Division 2010, 5:16
http://www.celldiv.com/content/5/1/16
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PML-RARα fusion protein which disrupts PML bodies,
abolishes formation of SAHF [20,21]. This study further
emphasizes the link between HIRA's localization to PML
bodies and formation of SAHF, because the failure of
mouse fibroblasts to obviously form punctate SAHF cor-
relates with a failure of HIRA to enter PML bodies in
these cells. Conversely, these results imply that recruit-
ment of HIRA to PML bodies is not directly linked to reg-
ulation of macroH2A. This is consistent with HIRA being
primarily involved in deposition of histone (H3/H4)2 het-
erotetramers, rather than H2A/H2B heterodimers [19].
In this study, we note a level of similarity between the
appearance of DAPI-stained nuclei of proliferating non-
senescent MEFs and senescent human cells. This similar-
ity at the microscopic level is not founded at the molecu-
lar level. Specifically, the bright-stained DAPI puncta in
mouse fibroblasts reflect the DNA sequence and struc-
ture of mouse pericentromeric heterochromatin [22,23].
However, the SAHF of senescent human cells largely
exclude pericentromeres and telomeres [20,21]. The simi-
larity at the microscopic level is potentially confusing,
and we caution that a punctate DAPI stain should not be
used to score senescence of MEFs, as it sometimes is in
human cells.
Conclusions
Previous works of others have found important func-
tional differences between the senescence programs of
mouse and human fibroblasts. As detailed in the Back-
ground, there are important differences in the role of the
pRB and p53 tumor suppressor pathways and telomeres.
The p53 pathway is dominant in mouse fibroblasts,
whereas in human cells either activation of the p53 or
pRB pathway leads to senescence. To these key differ-
ences between senescence of mouse and human fibro-
blasts, we add differences in the regulation and function
of the Wnt2-HIRA-SAHF pathway. Based on several
measures, this pathway is not overtly regulated at the
onset of senescence in MEFs, compared to its regulation
in human fibroblasts. However, our results obviously do
not exclude some role for HIRA in regulation of senes-
cence in MEFs, and future more detailed studies will be
required to fully define the similarities and differences in
chromatin regulation between mouse and human cells.
Methods
Cell Culture
IMR90 (ATCC) cell lines were cultured according to
ATCC guidelines in ambient oxygen. Experiments were
performed on IMR90 cells between population doubling
(PD) 20 and PD 35. Mouse Embryo Fibroblasts (MEFs)
were prepared from pooled wild type C57BL/6J embryos
that were gestational age E12-E14. The head and internal
organs were removed, and the torso was minced and dis-
persed in 0.25% trypsin + EDTA for 15 minutes in shak-
ing water bath at 37°C. Cells were spun, debris removed
and then plated. These cells were considered passage 0.
MEFs used in experiments were cultured in ambient oxy-
gen and experiments were performed between PD 1 and
PD 8. MEFs were cultured in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal bovine
serum. Cells were harvested 7 days post drug selection
for all assays. Mouse adult ear skin fibroblasts were
obtained as described [24].
DNA constructs and retroviral transduction
The following plasmids were used to produce retrovi-
ruses: pBabe-puro-H-RasG12V (a gift of Bill Hahn and
Bob Weinberg); pBabe-puro-GSK3βS9A from Addgene
(plasmid #14128). Retroviral-mediated gene transfer was
performed using the Phoenix packaging cells (Dr. Gary
Nolan, Stanford University). Phoenix cells were trans-
fected using Polyethylenimine (PEI), Linear MW 25,000
(Polysciences, Inc. Warrington, PA) sterile solution 1 mg/
ml. To one milliliter of serum free DMEM, 16 micro-
grams of retroviral plasmid DNA and 2 micrograms of a
plasmid encoding vesicular stomatitis virus glycoprotein
G (VSV-G) plus 38 micrograms of PEI was added, this
solution was briefly vortexed, left to sit for 10 minutes
and then added to Phoenix Cells. Twenty-four hours
later, media was changed on Phoenix cells. At 48 hours
post transfection, virus-containing medium was col-
lected, supplemented with 8 μg/ml of polybrene (Sigma),
and incubated with the target IMR90 or MEF cells at 37°C
for 24 hours. A second round of infection was performed
o n  t h e  s a m e  t a r g e t  c e l l s .  M E F s  a n d  I M R 9 0  c e l l s  w e r e
transduced in parallel and drug selected with 3 μg/ml or 1
μg/ml puromycin, respectively.
Immunofluorescence, antibodies, SAHF, and SA β-gal 
staining
Two color indirect immunofluorescence assays were per-
formed as described previously [26,30]. Anti-PML
(AB1370, Chemicon) Anti-PML for Additional file 1: Fig-
ure S1 (Upstate 05-718) Anti-V5 (Invitrogen) Anti-Ras
(BD Transduction Labatories Cat. No. 610001), Anti-beta
actin (Abcam clone AC-15) were from the indicated sup-
pliers. Anti-macroH2A and anti-HIRA antibodies were
described previously [20,31]. SAHF (DAPI foci) were
detected by staining with 0.13 μg/ml DAPI for 2 min at
room temperature (as opposed to standard conditions of
1 μg/ml for 5 min). SA beta-gal staining was performed as
described previously [32].
Coimmunoprecipitations
To prepare cell lysates, cells were washed once with PBS
and then collected by incubating in EBC-500 (50 mM
Tris-HCl pH8, 500 mM NaCl, 0.5% NP-40 + protease
inhibitors) for 20 minutes while rocking at 4°C, scrapedKennedy et al. Cell Division 2010, 5:16
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into microcentrifuge tubes, passed through a 22 gauge
needle five times and then spun for 10 minutes at 10,000
× g. Supernatant was used for immunoprecipitations.
Immunoprecipitation was performed using 2 mg of
extracted protein for 3 hours at 4°C. Antibodies used for
IP were WC15 [31] and M7023 secondary (Sigma, St.
Louis, MO). Immunoprecipitates were recovered after 1
hour incubation at 4°C with protein A Sepharose Beads
(Amersham/GE healthcare, Baie d'Urfé, QC, Canada).
Precipitates were washed five times with NETN (20 mM
Tris pH8, 1 mM EDTA, 0.5%NP-40, 100 mM NaCl). Pre-
cipitates were eluted in 50 ul of 1 × Laemmli sample buf-
fer , boiled 5 minutes, and separated by SDS-P AGE and
transferred to Immun-Blot PVDF membrane (Biorad,
Hercules, CA).
RT-PCR
Total RNA was prepared using Trizol (Invitrogen),
according to the manufacturer's instructions. Reverse
transcription-PCR (RT-PCR) was performed using the
Qiagen one-step RT-PCR kit, according to the manufac-
turer's instructions. Primers used for human GapDH
GAGAGACCCTCACTGCTG and GATGGTACAT-
GACAAGGTGC and for human Wnt2 ATGAACGCC
CCTCTCGGTGGAA and TGTCCTTGGCGCTTCC
CATC. For Mouse Wnt2: 5'-GTACATGAGAGCTACAG-
GTGG-3' and 5'-ACGGGCAAACTTGATCCCGTAGT
C-3' and GAPDH: 5'-GATGATGACCCTTTTGGCTC-
CACC-3' and 5'-CCACTCACGGCAAATTCAACGG
CA-3'. Quantitative RT-PCR was performed using the
one-step RT-PCR Master mix (Applied Biosystems). Real
time PCR and cDNA synthesis was performed using the
following mixture: 25 μl 2 × reaction buffer, 1.25 μl 40 ×
multiscribe, 2.5 μl 20 × primer/probe and 100 ng RNA in
a 50 μl total volume. Reactions were amplified and ana-
lyzed in triplicate using Chromo-4 real-time PCR detec-
tion system (Bio-rad). The following primer/probe sets
(Applied Biosystems) were used: human wnt2
Hs00608222, human beta-actin (endogenous control-
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